Evidence map›Paper›PMID 32746806›Full record

ArticleBMC neurology2020

KIF1A-related autosomal dominant spastic paraplegias (SPG30) in Russian families.

G E Rudenskaya, V A Kadnikova, O P Ryzhkova, L A Bessonova, E L Dadali, D S Guseva, T V Markova, D N Khmelkova, A V Polyakov

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Autosomal dominant neurodevelopmental disorders associated withZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

G E RudenskayaFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.ORCID https://orcid.org/0000-0002-8244-9367
V A KadnikovaFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia. vkadnikova@gmail.com.ORCID https://orcid.org/0000-0002-1245-4881
O P RyzhkovaFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.ORCID https://orcid.org/0000-0003-1285-9093
L A BessonovaFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.
E L DadaliFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.ORCID https://orcid.org/0000-0001-5602-2805
D S GusevaFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.ORCID https://orcid.org/0000-0003-3761-8595
T V MarkovaFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.ORCID https://orcid.org/0000-0002-2672-6294
D N Khmelkova"Genomed" Ltd, Moscow, Russia.
A V PolyakovFederal State Budgetary Scientific Institution "Research Centre for Medical Genetics" (RCMG), Moscow, Russia.ORCID https://orcid.org/0000-0003-4905-1303
Research Centre for Medical Genetics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpastic paraplegia type 30 (SPG30) caused by KIF1A mutations was first reported in 2011 and was initially considered a very rare autosomal recessive (AR) form. In the last years, thanks to the development of massive parallel sequencing, SPG30 proved to be a rather common autosomal dominant (AD) form of familial or sporadic spastic paraplegia (SPG),, with a wide range of phenotypes: pure and complicated. The aim of our study is to detect AD SPG30 cases and to examine their molecular and clinical characteristics for the first time in the Russian population.

methodsClinical, genealogical and molecular methods were used. Molecular methods included massive parallel sequencing (MPS) of custom panel 'spastic paraplegias' with 62 target genes complemented by familial Sanger sequencing. One case was detected by the whole -exome sequencing.

resultsAD SPG30 was detected in 10 unrelated families, making it the 3rd (8.4%) most common SPG form in the cohort of 118 families. No AR SPG30 cases were detected. In total, 9 heterozygous KIF1A mutations were detected, with 4 novel and 5 known mutations. All the mutations were located within KIF1A motor domain. Six cases had pure phenotypes, of which 5 were familial, where 2 familial cases demonstrated incomplete penetrance, early onset and slow relatively benign SPG course. All 4 complicated cases were caused by novel mutations without familial history. The phenotypes varied from severe in two patients (e.g. lack of walking, pronounced mental retardation) to relatively mild non-disabling symptoms in two others.

conclusionAD SPG30 is one of the most common forms of SPG in Russia, the disorder has pronounced clinical variability while pure familial cases represent a significant part.

Indexed as

AdolescentAdultChildChild, PreschoolFemaleHeterozygoteHigh-Throughput Nucleotide SequencingHumansIntellectual DisabilityKinesinsMaleMiddle AgedMutationParaplegiaPhenotypeRussiaKIF1A protein, humanKinesinsAdditional featuresAutosomal dominant spastic paraplegia type 30 (SPG30)Gene panelKIF1A geneMassive parallel sequencingPathogenic variantsPhenotypic variabilityPure phenotype

Identifiers

PMID32746806
PMCPMC7398351
OpenAlexW3046823867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.